MAINZ BIOMED B V's ticker is and the CUSIP is N5436L101. A total of 4 filers reported holding MAINZ BIOMED B V in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $7,000 | – | 477 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Greenwich Investment Management, Inc. | 14,724 | $136,000 | 0.10% |
| UBS Group AG | 1,364 | $13,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| CITIGROUP INC | 752 | $7,000 | 0.00% |